Holen Sie sich die Stockscreener-App
0.6427
1.29%
0.0082
Finanzdaten der Envoy Medical Inc-Aktie (COCH)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
30.77%
0.051
|
0.039 | 0.075 | 0.042 | 0.078 |
| Cost Of Revenue |
11.18%
0.278
|
0.313 | 0.211 | 0.203 | 0.234 |
| Research and Development |
14.00%
3.132
|
3.642 | 4.553 | - | - |
| Costs And Expenses |
6.30%
5.62
|
5.998 | 6.46 | 5.75 | 5.148 |
| Operating Income/Loss |
6.54%
-5.569
|
-5.959 | -6.385 | -5.708 | -5.07 |
| Nonoperating Income/Loss |
125.68%
-0.413
|
1.608 | -0.201 | -0.774 | -0.62 |
Net Income/Loss
|
37.49%
-5.982
|
-4.351 | -6.586 | -6.482 | -5.69 |
| Basic Average Shares |
50.92%
104.04
|
68.93 | - | 21.85 | 21.38 |
| Diluted Average Shares |
50.92%
104.04
|
68.93 | - | 21.85 | 21.38 |
| Basic Earnings Per Share |
12.50%
-0.07
|
-0.08 | - | -0.35 | -0.32 |
| Diluted Earnings Per Share |
12.50%
-0.07
|
-0.08 | - | -0.35 | -0.32 |
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):